MAPT and Alzheimer disease: Aggregation of amyloid-β into amyloid plaques (Aβ40 and Aβ42) and of tau into neurofibrillary tangles (total tau and phosphorylated tau, p-tau) are two CSF biomarkers typically linked to AD [16].